See also this year's filing and all EDGAR filings for this company.
PDF Report 0000891293_2021_CTI_Biopharma_CORP.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0000891293, CTI Biopharma CORP
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 54,325,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 719,000 |
| 3 | remainder_Assets | 3,197,000 |
| 4 | LiabilitiesCurrent | 17,038,000 |
| 5 | LiabilitiesNoncurrent | 1,174,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 16,751,211 |
| 9 | ResearchAndDevelopmentExpense | 26,699,447 |
| 10 | remainder_Expenses | 3,467,772 |
| 11 | remainder_Revenues | 1,108,188 |
| 12 | remainder_NetIncome | -4,939,895 |
| 13 | remainder_ComprehensiveNetIncome | -273,450 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 58,241,000 |
| 1 | Liabilities | 18,212,000 |
| 2 | Expenses | 46,918,430 |
| 3 | Revenues | 1,108,188 |
| 4 | StockholdersEquity | 40,029,000 |
| 5 | NetIncome | -50,750,137 |
| 6 | ComprehensiveNetIncome | -50,886,862 |
| 7 | BaseVar | 64,846,482 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.952 |
| 9 | EconomicCapitalRatio | 2.26 |
Edgar->Model Mapping
Feature Distribution
Change over Time
